DMK Group   Report issue

For profit
Founded: Zeven Germany (2010)

Organization Overview

First Clinical Trial
2017
NCT03577587
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

DMK Group